Editorial Board: Proteomics 2'22.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202270022
- Publication type:
- Article
Works matching IS 18628346 AND DT 2022 AND VI 16 AND IP 2
Results: 8
1
2
Descriptive proteomics of paired human vocal fold and buccal mucosa tissue.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100050
- By:
- Publication type:
- Article
3
Bortezomib is significantly beneficial for de novo pediatric AML patients with low phosphorylation of the NF‐κB subunit RelA.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100072
- By:
- Publication type:
- Article
4
Screening of differentially expressed proteins in placentas from patients with late‐onset preeclampsia.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100053
- By:
- Publication type:
- Article
5
Qualitative and quantitative proteomic and metaproteomic analyses of healthy human urine sediment.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100007
- By:
- Publication type:
- Article
6
Masthead: Proteomics 2'22.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202270023
- Publication type:
- Article
7
Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson's disease: a preliminary study.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202100010
- By:
- Publication type:
- Article
8
Front Cover.
- Published in:
- Proteomics - Clinical Applications, 2022, v. 16, n. 2, p. 1, doi. 10.1002/prca.202270021
- Publication type:
- Article